skip to main content

We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.

Edwards Lifesciences Achieves Another Major Patent Victory Against Medtronic

As reported by Law360, Paul, Weiss client Edwards Lifesciences obtained a victory when the United States Court of Appeals for the Federal Circuit affirmed a Central District of California's summary judgment decision holding that Medtronic's patent-in-suit was invalid. The Federal Circuit was not persuaded by Medtronic's attempt to overcome the summary judgment decision, characterizing its argument as an "attempt at linguistic gymnastics." The decision marks another major victory in Edwards Lifesciences' long-standing patent battle against Medtronic involving transcatheter heart valve technology and comes just a week after the Paul, Weiss team representing Edwards Lifesciences obtained a $393 million jury verdict against Medtronic.

The Paul, Weiss team included litigation partner Nicholas Groombridge, who argued the appeal, litigation partner Catherine Nyarady and of counsel John Nathan.

January 23, 2014

© 2020 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy